Literature DB >> 30121148

When Is a Maze Procedure a Maze Procedure?

James L Cox1, Andrei Churyla2, S Chris Malaisrie2, Jane Kruse2, Duc Thinh Pham2, Olga N Kislitsina2, Patrick M McCarthy2.   

Abstract

The initial surgical attempts to treat atrial fibrillation (AF) were isolation procedures designed to confine the arrhythmia to a specific area of the heart for relief of symptoms. The first surgical attempt to ablate AF was unsuccessful but was quickly followed by the Maze-I procedure on September 25, 1987. Because of several adverse sequelae of the Maze-I procedure, it was sequentially modified to the Maze-II and then Maze-III procedures. The Maze-IV procedure was introduced some 10 years later; these are the only 4 procedures that adhere to the concept of a maze pattern of lesions to ablate AF and leave both atria capable of being activated during normal sinus rhythm. The term maze procedure has become generic for virtually any operation designed to treat AF, but procedures that do not adhere to the concept of creating lesions of conduction block in the pattern of a maze are not maze procedures. These include, among others, the Wolf Mini-Maze, the Left-Sided Maze, and the 5-Box Maze, none of which are truly based on the maze-pattern concept. The cardinal feature of maze procedures that is necessary for both effectiveness and comparability to classical maze procedures includes lines of conduction block that preclude macro-reentry anywhere in either atrium while leaving both atria capable of activation by a sinus-generated impulse. Components essential to achieving this include appropriate lesions in both atria, the absence of gaps that allow electrical activity to bypass an intended line of block, and the absence of alternate pathways by which impulses can reach the intended maze exit.
Copyright © 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30121148     DOI: 10.1016/j.cjca.2018.05.008

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  The inadvertent compounding of misconceptions regarding the surgical treatment of atrial fibrillation in mitral valve patients.

Authors:  James L Cox; Patrick M McCarthy
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

2.  Box lesion or bi-atrial lesion set for atrial fibrillation during thoracoscopic epicardial ablation.

Authors:  Zhe Zheng; Haojie Li; Sheng Liu; Ge Gao; Chunyu Yu; Hengqiang Lin; Ying Meng
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-03

Review 3.  Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Authors:  Stanley Nattel; Philip T Sager; Jörg Hüser; Jordi Heijman; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

4.  Left Atrial Appendage Exclusion in Atrial Fibrillation Radiofrequency Ablation during Mitral Valve Surgery: A Single-Center Experience.

Authors:  C Lavalle; M Straito; E Chourda; S Poggi; G Frati; W Saade; A G M Marullo; M V Mariani; M Magnocavallo; F Miraldi
Journal:  Cardiol Res Pract       Date:  2021-08-02       Impact factor: 1.866

5.  Incidence and risk factors of acute kidney injury after maze operation in patients with rheumatic mitral valve disease.

Authors:  Yeiwon Lee; Ho Young Hwang; Hee Ju Hong; Sue Hyun Kim; Suk Ho Sohn; Jae Woong Choi; Kyung Hwan Kim
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

6.  Therapeutic monitoring of amiodarone and desethylamiodarone after surgical ablation of atrial fibrillation-evaluation of the relationship between clinical effect and the serum concentration.

Authors:  Erika Hrudikova; Milan Grundmann; Martin Kolek; Romana Urinovska; Ivana Kacirova
Journal:  Saudi Pharm J       Date:  2021-03-31       Impact factor: 4.330

Review 7.  Size matters in atrial fibrillation: the underestimated importance of reduction of contiguous electrical mass underlying the effectiveness of catheter ablation.

Authors:  Adam Hartley; Joseph Shalhoub; Fu Siong Ng; Andrew D Krahn; Zachary Laksman; Jason G Andrade; Marc W Deyell; Prapa Kanagaratnam; Markus B Sikkel
Journal:  Europace       Date:  2021-11-08       Impact factor: 5.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.